RMB advised Mediclinic on its R32-bn reverse take-over of Abu Dhabi-based Al Noor Hospitals Group plc and primary listing on the London Stock Exchange.
RMB is proud to have acted as joint financial adviser and investment bank to Mediclinic in their reverse take-over of LSE-listed Al Noor Hospitals Group, in an innovative transaction that substantially enhances Mediclinic’s presence in the United Arab Emirates. The transaction will result in Mediclinic becoming the third largest non-US private hospital group globally, with a primary listing on the LSE and secondary listing on the JSE. RMB also acted as joint mandated lead arranger, underwriter, debt adviser and bookrunner for the £1-bn (R24-bn) funding required for the transaction. The deal showcases RMB’s ability to provide holistic, multi-jurisdictional solutions for our clients.